Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,376,792 papers from all fields of science
Search
Sign In
Create Free Account
Advanced Pleural Malignant Mesothelioma
Known as:
Advanced Malignant Mesothelioma of Pleura
, Advanced Malignant Mesothelioma of the Pleura
, Malignant Pleural Mesothelioma, Advanced
Malignant mesothelioma that arises from the pleura and is classified as stage II, stage III, or stage IV.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
24 relations
Anorexia
CDKN2A gene
Chest
Chest Pain
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
MA05.06 Feasibility and Safety of Transarterial Chemoperfusion for Advanced Pleural Mesothelioma: Interim Results of a Phase 2 Study
B. Creelan
,
M. Pereira
,
+7 authors
B. Kis
Journal of Thoracic Oncology
2019
Corpus ID: 208452896
2017
2017
P3.03-035 Prognostic Role of hENT1 and RRM1 in Patients with Advanced Pleural Mesothelioma Treated with Second Line Gemcitabine Based Regimens: Topic: Mesothelioma Clinical
A. Cardona
,
O. Arrieta
,
+14 authors
R. Rosell
2017
Corpus ID: 79092278
2016
2016
P3.03-060 Characteristics and Long Term Outcomes of Advanced Pleural Mesothelioma in Latin America (MeSO-CLICaP): Topic: Mesothelioma Clinical
O. Arrieta
,
A. Cardona
,
+14 authors
R. Rosell
2016
Corpus ID: 79632989
2016
2016
A Phase II Study of PF‐03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207
P. Wheatley-Price
,
Q. Chu
,
+11 authors
P. Bradbury
Journal of Thoracic Oncology
2016
Corpus ID: 206600060
Review
2016
Review
2016
Pemetrexed Maintenance Therapy Following Bevacizumab-Containing First-Line Chemotherapy in Advanced Malignant Pleural Mesothelioma
X. Jing
,
Lei Zhou
,
Xin-dong Sun
,
Jin-ming Yu
,
Xue Meng
Medicine
2016
Corpus ID: 18811472
AbstractMalignant pleural mesothelioma (MPM) is a lethal disease with poor prognosis. The combination of cisplatin and pemetrexed…
Expand
2011
2011
VANTAGE 014: Vorinostat (V) in Patients With Advanced Malignant Pleural Mesothelioma (MPM) who Have Failed Prior Pemetrexed and Either Cisplatin or Carboplatin Therapy: A Phase III, Randomized…
L. Krug
,
H. Kindler
,
+7 authors
P. Baas
2011
Corpus ID: 71520529
2010
2010
The clinical impact of photodynamic therapy in thoracic surgery
J. Lindenmann
,
V. Matzi
,
N. Neuböck
,
A. Maier
,
F. Smolle-Jüttner
European surgery
2010
Corpus ID: 34845142
ZusammenfassungGRUNDLAGEN: Die Prognose von Patienten mit malignem Pleuramesotheliom, inoperablem fortgeschrittenen Ösophagus…
Expand
2004
2004
Induction chemotherapy, extrapleural pneumonectomy (EPP), and adjuvant hemithoracic radiation are feasible and effective for locally advanced malignant pleural mesothelioma (MPM)
R. Flores
,
L. Krug
,
+4 authors
V. Rusch
2004
Corpus ID: 201935887
7193 Background: Approximately 25% of patients (pts) with malignant pleural mesothelioma (MPM) prove unresectable at surgery and…
Expand
2001
2001
Intrathoracic Thermochemoradiotherapy for the Treatment of Locally-Advanced Malignant Pleural Mesothelioma -Treatment Protocol and Report of the Three Cases
K. Karasawa
,
T. Kaizu
,
Y. Niibe
,
H. Ishikawa
,
T. Okamura
,
Yoshiaki Tanaka
2001
Corpus ID: 78887289
Malignant pleural mesothelioma (MPM) is considered to carry dismal prognosis and reported surgical results indicate a median…
Expand
1997
1997
62 Phase II study of paclitaxel (Taxol®) and cisplatin (CDDP) in advanced pleural malignant mesothelioma (MM)
R. Caliandro
,
C. Boutin
,
+5 authors
P. Ruffié
1997
Corpus ID: 71421225
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE